{"news_desk": "Business", "print_page": "3", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Celgene announces $1 billion collaboration with Juno Therapeutics under which it will acquire about 9.1 million Juno shares; deal will allow Juno to compete more effectively with Novartis in emerging market for cancer drugs that harness immune system to attack tumors.", "type_of_material": "News", "word_count": "708", "lead_paragraph": "As part of the deal, Celgene will acquire 9.1 million shares of Juno, a leader in cancer drugs that use patients\u2019 immune systems to attack tumors.", "pub_date": "2015-06-30T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Celgene to Pay $1 Billion for Biotech Collaboration With Juno", "print_headline": "Celgene to Pay $1 Billion for Juno Collaboration"}, "snippet": "As part of the deal, Celgene will acquire 9.1 million shares of Juno, a leader in cancer drugs that use patients\u2019 immune systems to attack tumors.", "multimedia": [{"height": 126, "url": "images/2015/06/30/business/30IMMUNE/30IMMUNE-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/06/30/business/30IMMUNE/30IMMUNE-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 414, "url": "images/2015/06/30/business/30IMMUNE/30IMMUNE-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "414", "xlarge": "images/2015/06/30/business/30IMMUNE/30IMMUNE-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/06/30/business/30IMMUNE/30IMMUNE-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/06/30/business/30IMMUNE/30IMMUNE-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/06/30/business/celgene-to-pay-1-billion-for-biotech-collaboration-with-juno.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Celgene Corporation", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Juno Therapeutics Inc", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Novartis AG", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Biotechnology and Bioengineering", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Cancer", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Tumors", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}], "blog": [], "_id": "5591c26038f0d846820c78c9", "source": "The New York Times"}